CMS Administrator Seema Verma and HHS Secretary Alex Azar told to work out their differences; the debate continues on whether health insurance coverage affects mortality rates; Facebook is accused of misleading the public about the benefits of pre-exposure prophylaxis (PrEP).
The acrimonious relationship between Verma and Azar will be under speculation once again when they convene at the White House on Thursday at the behest of Mick Mulvaney, acting White House chief of staff, and President Trump, according to The New York Times. Verma has been in the news lately for requesting taxpayer reimbursement for lost luggage and jewelry totaling $47,000, as well as misusing taxpayer dollars on communications consultants. Representative Joe Kennedy, D-Massachusetts, called for her resignation earlier this week. Former HHS Secretary Tom Price and Interior Secretary Ryan Zinke were forced to resign following similar accusations. Azar, meanwhile, lost his fight to eliminate drug rebates in order to reduce drug prices in July after President Trump denied the proposal.An estimated 700 lives may have been saved thanks to letters the IRS mailed to 3.9 million uninsured Americans 3 years ago reminding them of their fine for not having health insurance and offering tips for how to get coverage, The New York Times reports. This unintentional study result came thanks to an Obama administration budget shortfall preventing letters from going to an additional 600,000 Americans, which led to a randomized controlled trial. That health coverage under the Affordable Care Act actually can save lives has been a hot debate topic, despite reports showing Medicaid expansion did just that, and a working paper from 3 Treasury Department officials touting increased sign-ups. In December 2017, Congress struck down the much-debated Affordable Care Act mandate penalizing individuals for not carrying health coverage.The Human Rights Campaign, GLAAD, amfAR, and the Gay Men's Health Crisis are among the 52 advocacy organizations demanding that the social media platform immediately take down ads purported to recruit plaintiffs for a class-action lawsuit involving pre-exposure prophylaxis (PrEP) drug Truvada, The Advocate reports. The HIV-prevention drug has a 99% effective rate when taken daily, but the ads tout it is extremely dangerous because of adverse effects that include decreased bone density and kidney function. Meanwhile, supporters worry the ads will scare away HIV-negative individuals at risk of contracting the disease who are already voicing their PrEP fears because of these ads.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More